LBMC Investment Advisors’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-3,899
Closed -$245K 201
2024
Q3
$245K Hold
3,899
0.02% 172
2024
Q2
$230K Hold
3,899
0.02% 173
2024
Q1
$311K Hold
3,899
0.03% 139
2023
Q4
$308K Sell
3,899
-260
-6% -$18.5K 0.03% 125
2023
Q3
$288K Buy
4,159
+260
+7% +$18.4K 0.03% 124
2023
Q2
$270K Hold
3,899
0.03% 131
2023
Q1
$290K Hold
3,899
0.03% 126
2022
Q4
$363K Sell
3,899
-220
-5% -$21.2K 0.04% 110
2022
Q3
$393K Hold
4,119
0.05% 100
2022
Q2
$382K Buy
4,119
+1,000
+32% +$97.6K 0.04% 96
2022
Q1
$316K Sell
3,119
-20
-0.6% -$2.1K 0.03% 117
2021
Q4
$324K Buy
3,139
+240
+8% +$22.2K 0.03% 128
2021
Q3
$266 Hold
2,899
0.02% 135
2021
Q2
$242K Buy
+2,899
New +$237K 0.02% 147

Other funds holding CVS

LBMC Investment Advisors's CVS Position: Q4 2024 in Review

LBMC Investment Advisors sold out of CVS Health (CVS) in Q4 2024, closing a stake of 3,899 shares — an estimated $245K sold.

LBMC Investment Advisors first reported a position in CVS in Q2 2021 and held it in 14 quarters. The position peaked at $393K in Q3 2022. 1,668 funds tracked by Wall St. Rank hold CVS as of Q4 2024.

  • LBMC Investment Advisors reported no remaining CVS Health position as of Q4 2024 after selling out during the quarter.
  • LBMC Investment Advisors sold 3,899 CVS Health shares in Q4 2024, an estimated $245K.
  • LBMC Investment Advisors first reported a position in CVS Health in Q2 2021 and held it in 14 quarters.
  • LBMC Investment Advisors's CVS Health position peaked at $393K in Q3 2022.
  • 1,668 funds tracked by Wall St. Rank held CVS Health as of Q4 2024.

Based on LBMC Investment Advisors's 13F filing for Q4 2024, filed 16 Jan 2025.